In a patient with intractable headache and possible seizure who has a 5 × 19 mm middle cranial fossa arachnoid cyst without mass effect or midline shift, could the cyst be the cause of her symptoms?

A 5 × 19 mm middle cranial fossa arachnoid cyst without mass effect or midline shift is extremely unlikely to be causing this patient's intractable headache or seizures, and observation is the appropriate management.

Clinical Reasoning

The size and imaging characteristics argue strongly against causation. According to the 2025 Pituitary Society guidelines, observation is recommended for small arachnoid cysts (<10 mm) and larger asymptomatic arachnoid cysts (≥10 mm) 1. Your patient's cyst at 19 mm in maximal dimension falls into this category, particularly given the absence of mass effect or midline shift—two critical features that would suggest symptomatic compression.

Key Distinguishing Features

The literature provides clear parameters for when arachnoid cysts become symptomatic:

• Size threshold: Most symptomatic middle cranial fossa cysts measure 5-20 mm in diameter 2, but critically, they demonstrate mass effect or complications
• Mass effect is essential: Parenchymal lesions with cystic areas >20 mm accompanied by midline shift are more likely to be symptomatic 2
• Your patient has neither: At 19 mm with no mass effect or shift, this cyst lacks the compressive features associated with symptoms

Evidence from Clinical Studies

Research on arachnoid cysts and symptoms reveals important patterns:

For headache: A 2014 pediatric study found that of 11 patients with arachnoid cysts identified during headache evaluation, only 2 had symptomatic cysts—both presented with ruptured cysts, midline shifting, and large subdural collections 3. The other 9 patients with mild or no mass effect were considered to have headaches unrelated to their cysts 3.

For seizures: While 22-30% of patients with arachnoid cysts may present with seizures 4, 5, the relationship is controversial. A 2024 study found that in 26 patients with both epilepsy and arachnoid cysts, only one patient had epileptic discharge originating from the same region as the cyst 5. This suggests most seizures in patients with arachnoid cysts are coincidental rather than causative.

Clinical Pitfalls to Avoid

Do not assume causation based on presence alone. Arachnoid cysts are found in approximately 1% of brain imaging studies and are frequently incidental 4, 6. The critical error would be attributing symptoms to an incidental finding and pursuing unnecessary surgery.

Look for alternative explanations:

• For intractable headache: Evaluate for primary headache disorders (migraine, tension-type), particularly if there is family history of migraine 3
• For seizures: Pursue standard epilepsy workup including EEG to identify the actual epileptogenic focus 5

When Would Surgery Be Indicated?

Based on the 2025 Pituitary Society guidelines, surgery for arachnoid cysts should be considered only when 1:

1. Enlarging cysts with visual or hormonal dysfunction
2. Severe refractory headache after multidisciplinary evaluation (including expert neurology) in cysts <10 mm
3. Complications occur: spontaneous hemorrhage, hydrocephalus, or significant mass effect 7, 6

Your patient meets none of these criteria.

Recommended Management Approach

Observation with serial imaging is appropriate 1. The natural history of arachnoid cysts shows that most remain stable or even regress over time 1.

Treat the symptoms directly:

• Optimize headache management with appropriate medications for the specific headache type
• Manage seizures with antiepileptic drugs based on seizure semiology and EEG findings 5

Follow-up imaging should be considered if symptoms worsen or new neurological signs develop, particularly looking for cyst enlargement, hemorrhage, or development of mass effect 1.

The absence of mass effect and midline shift in your patient is the decisive factor—these imaging features are what separate incidental findings from symptomatic lesions requiring intervention.